<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.540  Dexamethasone oral dosage forms.

Sec. 520.540a  Dexamethasone powder.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each packet contains 10 milligrams (mg) of dexamethasone.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use in cattle and horses--(1) Amount. Administer 5 to 10 mg per animal the first day then 5 mg per day as required by drench or by sprinkling on a small amount of feed.</p><p class="depth0"><em>(1)</em> Amount. Administer 5 to 10 mg per animal the first day then 5 mg per day as required by drench or by sprinkling on a small amount of feed.</p><p class="depth0"><em>(2)</em> Indications for use. As supportive therapy following parenteral steroid administration for management or inflammatory conditions such as acute arthritic lameness, and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Do not use in horses intended for human consumption.
[79 FR 28819, May 20, 2014]


Sec. 520.540b  Dexamethasone tablets and boluses.</p><p class="depth0"><em>(a)(1)</em> Specifications. Each bolus is half-scored and contains 10 milligrams of dexamethasone.</p><p class="depth0"><em>(1)</em> Specifications. Each bolus is half-scored and contains 10 milligrams of dexamethasone.</p><p class="depth0"><em>(2)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(3)</em> Conditions of use in cattle and horses--(i) Amount. Administer orally 5 to 10 milligrams on the first day, then 5 milligrams per day as required.</p><p class="depth0"><em>(i)</em> Amount. Administer orally 5 to 10 milligrams on the first day, then 5 milligrams per day as required.</p><p class="depth0"><em>(ii)</em> Indications for use. As supportive therapy following parenteral steroid administration for management or inflammatory conditions such as acute arthritic lameness, and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.</p><p class="depth0"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Do not use in horses intended for human consumption.</p><p class="depth0"><em>(b)(1)</em> Specifications. Each tablet contains 0.25 milligram of dexamethasone.</p><p class="depth0"><em>(1)</em> Specifications. Each tablet contains 0.25 milligram of dexamethasone.</p><p class="depth0"><em>(2)</em> Sponsors. See Nos. 000061 and 061623 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(3)</em> Conditions of use in dogs and cats--(i) Amount. Dogs: Administer orally 0.25 to 1.25 milligrams per day for up to 7 days. Cats: Administer orally 0.125 to 0.5 milligrams per day for up to 7 days.</p><p class="depth0"><em>(i)</em> Amount. Dogs: Administer orally 0.25 to 1.25 milligrams per day for up to 7 days. Cats: Administer orally 0.125 to 0.5 milligrams per day for up to 7 days.</p><p class="depth0"><em>(ii)</em> Indications for use. As an anti-inflammatory agent.</p><p class="depth0"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 26273, June 23, 1975, as amended at 44 FR 7130, Feb. 6, 1979; 50 FR 49372, Dec. 2, 1985; 52 FR 7832, Mar. 13, 1987; 55 FR 8461, Mar. 8, 1990; 66 FR 14073, Mar. 9, 2001; 68 FR 4914, Jan. 31, 2003; 70 FR 16934, Apr. 4, 2005; 79 FR 28819, May 20, 2014]


Sec. 520.540c  Dexamethasone chewable tablets.</p><p class="depth0"><em>(a)</em> Specifications. Each half-scored tablet contains 0.25 milligram of dexamethasone.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use in dogs--(1) Amount. Administer by free-choice feeding or crumbled over food 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.</p><p class="depth0"><em>(1)</em> Amount. Administer by free-choice feeding or crumbled over food 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.</p><p class="depth0"><em>(2)</em> Indications for use. As supportive therapy in nonspecific dermatosis and inflammatory conditions.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[44 FR 7130, Feb. 6, 1979, as amended at 56 FR 50653, Oct. 8, 1991; 60 FR 55659, Nov. 2, 1995; 79 FR 28820, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
